文献速递小儿神经外科与脑积水神经重症

脑积水的再入院与再手术:全年龄段人群分析

Readmission and reoperation for hydrocephalus: a population-based analysis across the spectrum of age.
PubMed 文献 · J Neurosurg · 2020-05-29

基于美国全国再入院数据库2015年数据,分析脑积水患者全年龄段再入院与再手术情况。30天再入院率各年龄组间无显著差异,但30天再手术率成人最高(47.4%),婴儿34.9%,儿童39.2%,老年人32.4%。脑室腹腔分流术1年再手术率达74.2%,显著高于内镜下第三脑室造瘘术的34.5%。

要点

  • 成人脑积水再手术率高于婴幼儿和老年人。
  • 分流术1年再手术率74.2%,远高于第三脑室造瘘术34.5%。
  • 各年龄组30天再入院率无显著差异,但再入院费用高昂。

核心结论

  • 美国脑积水主要累及成人,基于人群的手术结局显著差于研究中心报告,高分流再手术率是主要原因。

研究设计与样本

  • 基于美国全国再入院数据库2015年数据的人群回顾性分析,纳入脑积水诊断出院记录,以首次出院为索引入院,首次确定性手术为索引手术,分析再入院和再手术结局。

主要发现

  • 30天再入院率各年龄组为15.6%至16.8%,无显著差异。
  • 30天再手术率婴儿34.9%,儿童39.2%,成人47.4%,老年人32.4%,差异显著。
  • 估算1年再手术率分流置入74.2%,分流翻修63.9%,内镜下第三脑室造瘘仅34.5%。

临床怎么用

  • 临床应关注成人脑积水患者的高再手术风险,尤其分流术后。
  • 内镜下第三脑室造瘘术的再手术率低于分流术,选择术式时可参考。

局限性

  • 数据来源于行政数据库,可能存在编码误差和混杂因素。
  • 仅纳入2015年数据,随访截至当年年底,可能低估长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hydrocephalus is a common, chronic illness that generally requires lifelong, longitudinal, neurosurgical care. Except at select research centers, surgical outcomes in the United States have not been well documented. Comparative outcomes across the spectrum of age have not been studied. METHODS: Data were derived for the year 2015 from the Nationwide Readmissions Database, a product of the Healthcare Cost and Utilization Project of the Agency for Healthcare Research and Quality. In this data set patients are assigned state-specific codes that link repeated discharges through the calendar year. Discharges with diagnostic codes for hydrocephalus were extracted, and for each patient the first discharge defined the index admission. The study event was readmission. Observations were censored at the end of the year. In a similar fashion the first definitive surgical procedure for hydrocephalus was defined as the index operation, and the study event was reoperation for hydrocephalus or complications. Survival without readmission and survival without reoperation were analyzed using life tables and Kaplan-Meier plots. RESULTS: Readmission rates at 30 days ranged between 15.6% and 16.8% by age group without significant differences. After the index admission the first readmission alone generated estimated hospital charges of $2.25 billion nationwide. Reoperation rates at 30 days were 34.9% for infants, 39.2% for children, 47.4% for adults, and 32.4% for elders. These differences were highly significant. More than 3 times as many index operations were captured for adults and elders as for infants and children. Estimated 1-year reoperation rates were 74.2% for shunt insertion, 63.9% for shunt revision, but only 34.5% for endoscopic third ventriculostomy. Univariate associations with survival without readmission and survival without reoperation are presented. CONCLUSIONS: In the United States hydrocephalus is predominantly a disease of adults. Surgical outcomes in this population-based study were substantially worse than outcomes reported from research centers. High reoperation rates after CSF shunt surgery accounted for this discrepancy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. LeHanka A, Piatt J. Readmission and reoperation for hydrocephalus: a population-based analysis across the spectrum of age. J Neurosurg. 2020. PMID: 32470941. doi:10.3171/2020.3.JNS20528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。